AustraliaDaily Briefs

Daily Brief Australia: Mayne Pharma, Guzman Y Gomez, Apiam Animal Health, S&P/ASX 200, Bell Financial and more

In today’s briefing:

  • Mayne Pharma (MYX AU): Got to Know when to Hold ‘em, when to Fold ’em
  • Guzman IPO Lockup – Last of the Lockups for a US$750m+ Release
  • Apiam Animal Health (AHX AU): Adamantem’s NBIO
  • Global Markets Tactical Outlook WEEKLY: August 18 – August 22
  • Bell Financial Group Ltd – A strong July lmost offsets H1 FY25 decline


Mayne Pharma (MYX AU): Got to Know when to Hold ‘em, when to Fold ’em

By Arun George

  • On 17 May, Cosette asserted that a material adverse change had occurred. Mayne Pharma (MYX AU) disputes the claim with court proceedings set to start on 22 September. 
  • Mayne’s FY25 results on 29 August should provide incremental clarity, but not a definite answer, on the MAC breach relating to maintainable EBITDA (decline by at least A$10.76 million).
  • The outcome of the trial remains uncertain as both Mayne and Cosette have valid arguments. Risk/reward is attractive – upside (43.1% to offer) vs the downside (22.3% to deal-break price).  

Guzman IPO Lockup – Last of the Lockups for a US$750m+ Release

By Sumeet Singh

  • Guzman Y Gomez (GYG AU) raised around US$221m in its Australian IPO. Its final IPO linked lockup expiry is due soon.
  • GYG is a quick service restaurant business with more than 200 restaurants globally. It mainly focuses on fresh, made-to-order, Mexican-inspired food.
  • In this note, we will talk about the lockup dynamics and possible placement.

Apiam Animal Health (AHX AU): Adamantem’s NBIO

By David Blennerhassett

  • Apiam Animal Health (AHX AU), Australia’s largest rural and regional veterinary group, has announced a non-binding indicative Offer from PE outfit Adamantem Capital.  
  • Adamantem is offering A$0.88/share, a 64.5% premium to last close. If terms are firmed, shareholders will also be afforded a partial scrip option into an unlisted bidco. 
  • Adamantem has also entered into a call option for 19.9% of shares out at A$0.88/share. An independent board committee are assessing the approach. Due diligence not yet granted.

Global Markets Tactical Outlook WEEKLY: August 18 – August 22

By Nico Rosti


Bell Financial Group Ltd – A strong July lmost offsets H1 FY25 decline

By Research as a Service (RaaS)

  • Bell Financial Group Ltd (ASX:BFG) is a diversified provider of financial products and software solutions within, and increasingly outside, its traditional full-service stockbroking business.
  • BFG has reported a headline NPAT decline of 44% to $9.3m for H1 FY25.
  • RaaS had forecast a decline of 32% excluding investment losses on the back of lower ECM activity, which was the case and saw the retail and institutional (broking) business move from a profit to a loss over the period (a $9.1m turnaround).

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars